BIORELEASE DESLORELIN

Hazard statements (CLP)

H302, H313, H318, H361, H413, H433

Code

Statements

H302

Harmful if swallowed

2.1 Classification of the substance or mixture

HAZARDOUS ACCORDING TO NZ ENVIRONMENTAL PROTECTION AUTHORITY CRITERIA

Physical hazards

Not classified as a Physical Hazard

Health hazards

6.1D - Substances that are acutely toxic: Oral 6.1E - Substances that are acutely toxic: Dermal 6.3B - Substances that are mildly irritating to the skin 6.8B - Substances that are suspected human reproductive or developmental toxicants 8.3A - Substances that are corrosive to ocular tissue

Environmental hazards

9.1D - Substances that are slightly harmful in the aquatic environment or are otherwise designed for biocidal action 9.3C - Substances that are harmful to terrestrial vertebrates

Signal word

DANGER

Hazard statements

H302 Harmful if swallowed. H313 May be harmful in contact with skin. H318 Causes serious eye damage. H361 Suspected of damaging fertility or the unborn child. H413 May cause long lasting harmful effects to aquatic life. H433 Harmful to terrestrial vertebrates.

Prevention

P102 Keep out of reach of children. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment.

Response

P101 If medical advice is needed, have product container or label at hand. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P310 Immediately call a POISON CENTER or doctor/physician. P330 Rinse mouth. P331 Do NOT induce vomiting.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with relevant regulations.

2.3 Other hazards

This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. Pregnant women and others of childbearing age should exercise caution when handling this product. Accidental administration may lead to a disruption of the menstrual cycle. Direct contact with the skin should therefore be avoided and any contact areas should be washed immediately with soap and water if exposure does occur. As with all injectable drugs causing profound physiological effects, routine precautions should be employed by practitioners when handling and using BioRelease Deslorelin (BRD) to prevent accidental injection.